Top Markets
Coin of the day
GBS Inc. GBS Inc.

GBS Inc.

GBS
Classifica tra le azioni #33710
Operating across North America and the Asia-Pacific region, GBS Inc.... Operating across North America and the Asia-Pacific region, GBS Inc. specializes in biosensor diagnostic technology. Its key product is the Saliva Glucose Biosensor, an innovative organic thin-film transistor designed for diabetes management that quantifies glucose levels directly from saliva. The company is also actively advancing a SARS-CoV-2 Biosensor, intended as a supplementary diagnostic tool to existing RNA virus detection tests, and is constructing a broad biosensor platform covering diagnostic modalities such as biochemistry, immunology, tumor markers, hormones, and nucleic acids. GBS Inc. maintains a research agreement with the Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic solutions. Founded in 2016 and headquartered in New York, New York, the company adopted its current name, GBS Inc., in September 2019, having previously operated as Glucose Biosensor Systems (Greater China) Holdings, Inc. It operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Prezzo delle azioni
$0.4732
Ultima sincronizzazione: 2022-10-26
Capitalizzazione di mercato
$7.05M
Variazione (1 giorno)
-0.03%
Variazione (1 anno)
0.00%
Paese
US
Scambia GBS Inc. (GBS)

Categoria

Storico del prezzo dell'azione per GBS Inc. (GBS)
Prezzo di chiusura più alto: $0.49 il 2022-10-01

Prezzo di chiusura più basso: $9.14 il 2020-12-01
Storico del prezzo dell'azione di GBS Inc. dal 2020 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2022 -69.81%
2021 -82.27%
2020 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$111.15 -15.64%
US
$339.00 -11.24%
US
$91.19 -1.97%
IE
$51.77 -49.83%
US
$91.49 16.90%
US